Zura Bio (ZURA) Institutional Ownership → Better than Bitcoin? The Biotech Stock with 46,751% Potential (From Behind the Markets) (Ad) Free ZURA Stock Alerts $4.41 +0.79 (+21.82%) (As of 04/26/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Zura Bio (NASDAQ:ZURA)CurrentInstitutional OwnershipPercentage61.14%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$82.99MNumber ofInstitutional Sellers(last 12 months)0 Get ZURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Zura Bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ZURA Institutional Buying and Selling by Quarter Ad Behind the MarketsBetter than Bitcoin? The Biotech Stock with 46,751% Potential4x Better than Bitcoin Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December.Get the name of the stock here >>> Zura Bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/15/2024Forefront Analytics LLC21,229$99K0.0%+46.8%0.049% 2/13/2024Armistice Capital LLC1,824,000$8.52M0.1%+15.4%4.233% 11/15/2023Armistice Capital LLC1,580,000$10.43M0.2%+66.3%3.667% 11/14/2023Lynx1 Capital Management LP9,917$65K0.0%N/A0.023% 11/13/2023Eisler Capital US LLC100,000$660K0.0%N/A0.232% 11/13/2023Silverarc Capital Management LLC404,040$2.67M0.8%+152.5%0.938% 11/8/2023Forefront Analytics LLC14,464$95K0.1%N/A0.034% 10/24/2023Bank of New York Mellon Corp33,973$224K0.0%N/A0.079% 10/24/2023 Raymond James & Associates77,356$511K0.0%+14.0%0.180% 8/15/2023Silverarc Capital Management LLC160,000$1.31M0.4%N/A0.591% 8/15/2023Suvretta Capital Management LLC2,850,000$23.37M1.2%N/A10.536% 8/14/2023Great Point Partners LLC3,295,000$27.02M5.3%N/A12.181% 8/14/2023Deep Track Capital LP2,523,000$20.69M1.0%N/A5.855% 8/10/2023Monashee Investment Management LLC240,000$1.97M0.5%N/A0.887% 8/4/2023American International Group Inc.3,649$30K0.0%N/A0.013% 7/25/2023 Raymond James & Associates67,875$557K0.0%N/A0.251% (Data available from 1/1/2016 forward) ZURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ZURA shares? During the previous two years, 12 institutional investors and hedge funds held shares of Zura Bio. The most heavily invested institutionals were Great Point Partners LLC ($27.02M), Suvretta Capital Management LLC ($23.37M), Deep Track Capital LP ($20.69M), Armistice Capital LLC ($8.52M), Silverarc Capital Management LLC ($2.67M), Monashee Investment Management LLC ($1.97M), and Eisler Capital US LLC ($660K).Learn more on ZURA's institutional investors. What percentage of Zura Bio stock is owned by institutional investors? 61.14% of Zura Bio stock is owned by institutional investors. Learn more on ZURA's institutional investor holdings. Which institutional investors have been buying Zura Bio stock? Of the 12 institutional investors that purchased Zura Bio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Great Point Partners LLC ($3.30M), Suvretta Capital Management LLC ($2.85M), Deep Track Capital LP ($2.52M), Armistice Capital LLC ($874K), Silverarc Capital Management LLC ($404.04K), Monashee Investment Management LLC ($240K), and Eisler Capital US LLC ($100K). How much institutional buying is happening at Zura Bio? Institutional investors have bought a total of 10,432,164 shares in the last 24 months. This purchase volume represents approximately $82.99M in transactions. Related Companies: AGEN Major Shareholders OMGA Major Shareholders DBVT Major Shareholders BCAB Major Shareholders CLLS Major Shareholders MOLN Major Shareholders CRDL Major Shareholders OTLK Major Shareholders VIGL Major Shareholders LIFE Major Shareholders This page (NASDAQ:ZURA) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThey say it’s ‘unstoppable’ – How I made 43,509% Investing DailyThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyProtect Your Bank Account Before It’s Too LateWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zura Bio Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
